Shaun Grady is responsible for representing AstraZeneca’s whole enterprise across the UK.

In this role, reporting to CEO Pascal Soriot, Shaun works closely with relevant senior leaders

across AstraZeneca to champion and support our science and R&D function, operations and

manufacturing, commercial business, and our corporate priorities across the life sciences

ecosystem in the UK. Shaun also manages critical relationships with senior Government

representatives, business leaders and industry associations, as well as leading on advocacy

for key policy priorities. As UK Chair he also represents AstraZeneca’s global enterprise,

where we support and leverage the UK's unique diplomatic and economic networks to

improve trade and international cooperation in life sciences. Additionally, Shaun chairs the

UK Leadership Team, the UK Employee Forum and the UK Inclusion and Diversity working

group.

Before becoming the Chair of AstraZeneca UK, Shaun led the company’s business

development function where he has worked for over 20 years, and before that was a

member of the legal team working on corporate transactions. Shaun has played a central

role in almost every major business development activity during his time with the company,

including the merger of Astra and Zeneca, the acquisition of Cambridge Antibody

Technology (CAT), and later MedImmune and Amylin, and the buy-out of Bristol-Myers’

Squibb’s interest in the AstraZeneca-BMS Diabetes Alliance. More recently, Shaun led the

transaction team for AstraZeneca’s global ADC collaborations with Daichi Sankyo, and the

acquisition of Gracell, Icosovax and Fusion, as well as the collaboration with Ecogene.

Shaun is a Board member at the BioIndustry Association (BIA) and CBI President’s

Committee, is Chairman of the Board of Directors of Cambridge United Football Club, and a

Board member at Cambridge Arts Theatre, and at Prostate Cancer Research, as well as an

Honorary Fellow at The University of Cambridge Judge Business School and Lucy

Cavendish College Cambridge.